CLOV CLOVER HEALTH INV CORP

Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference

Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference

WILMINGTON, Del., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andrew Toy, will present at the J.P. Morgan 2026 Healthcare Conference on Thursday, January 15, 2026, at 11:15 a.m. Eastern Time.

A live webcast and replay of the presentation and Q&A session will be accessible on Clover Health's investor relations website at .

About Clover Health:

Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on , , , and in as well as the earlier identification and management of and .

Investor Relations:

Ryan Schmidt

Press Inquiries:



EN
16/12/2025

Underlying

CLOVCLOVER HEALTH INV CORP

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLOVER HEALTH INV CORP

 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare C...

Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference WILMINGTON, Del., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andrew Toy, will present at the J.P. Morgan 2026 Healthcare Conference on Thursday, January 15, 2026, at 11:15 a.m. Eastern Time. A live webcast and replay of the presentation and Q&A session will be accessible on Clover Health's investor relations website at . About Clover Health:Clover Health (Nasdaq: CLOV) is a p...

10h / 41m 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health to Participate in Upcoming 2025 Citi Global Healthcare C...

Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 Citi Global Healthcare Conference on Thursday, December 4, 2025, at 11:15 a.m. Eastern Time. A live webcast and replay of the presentation will be accessible on Clover Health's investor relations website at . About Clover Health:Clover Health (Nasdaq: CLOV) is a physician en...

November 17, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health Reports Third Quarter 2025 Results

Clover Health Reports Third Quarter 2025 Results Business Highlights: Generates third quarter year-to-date positive Adjusted EBITDA profitability, on a wide network, while growing membership by 35% and revenue by 39% year-over-year, despite a greater proportion of new members relative to returning member baseHigh coverage of Clover Assistant, including within new cohorts, will result in improved total cost of care Strong retention, above-market growth, and profitable returning member cohorts position Clover for improved positive FY26 Financial Results Financial Results: Third quarter 202...

November 4, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Clover Health Announces Chelsea Clinton to Step Down from Board Follow...

Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that Chelsea Clinton, the longest-serving member of its Board of Directors, having joined the Board in early 2017, will conclude her service as of October 31, 2025. During her over eight years of dedicated service, Ms. Clinton played a pivotal role in guiding Clover’s evolution from a privately held company serving 30,000 members to a...

October 31, 2025 1 EN
 PRESS RELEASE
Free
CLOV CLOVER HEALTH I...

Primary Care Physician Use of Counterpart Assistant (CA) Technology As...

Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease. SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician-enablement platform, today released a w...

October 30, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch